Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders Equity (Deficit)

v3.19.1
Consolidated Statements of Stockholders Equity (Deficit) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Non-Controlling Interest [Member]
Total
Beginning balance at Dec. 31, 2016 $ 20 $ 463 $ 49,879,161 $ (57,942,548) $ (1,060,390) $ (163,848) $ (9,287,142)
Beginning balance, shares at Dec. 31, 2016 195,501 4,638,118          
Stock-based compensation expense $ 78 1,976,738 1,976,816
Stock-based compensation expense, shares 775,000          
Issuance of Series D Preferred Stock $ 13 678,700 678,713
Issuance of Series D Preferred Stock, shares 125,688          
Conversion of Series B Preferred Stock $ (20) $ 20
Conversion of Series B Preferred Stock, shares (195,500) 195,500          
Conversion of Series D Preferred Stock $ (13) $ 63 107,224 107,274
Conversion of Series D Preferred Stock, shares (125,688) 628,438          
Warrants converted to Series E preferred stock $ 1 21,525,410 21,525,411
Warrants converted to Series E preferred stock, shares 5,512          
Common stock issued for note conversion $ 181 1,445,871 1,446,052
Common stock issued for note conversion, shares 1,807,565          
Beneficial conversion feature 4,017,729 4,017,729
Proceeds received from private placement $ 349 16,074,067 16,074,416
Proceeds received from private placement, shares   3,492,047          
Issue common stock for conversion of Warrants $ 62 1,183,966 1,184,028
Issue common stock for conversion of Warrants, shares   619,250          
Warrant liability     137,334 137,334
Convertible debt warrant repricing
Common stock issued for account payable $ 32 435,457 435,489
Common stock issued for account payable, shares   320,449          
Loss on sale of companies (42,576) (42,576)
Gain on extinguishment of warrant liability (305,358) (305,358)
Par value adjustment and additional shares issued due to reverse split
Par value adjustment and additional shares issued due to reverse split, shares 1,414  
Currency translation gain\loss $ 609,656 609,656
Net Loss (31,333,569) 163,848 (31,333,569)
Ending balance at Dec. 31, 2017 $ 1 $ 1,248 97,113,723 (89,276,117) (450,734) 7,388,121
Ending balance, shares at Dec. 31, 2017 5,513 12,477,781          
Stock-based compensation expense   $ 44 1,425,639 1,425,683
Stock-based compensation expense, shares   443,400          
Common stock issued for note conversion   $ 382 3,055,206 3,055,588
Common stock issued for note conversion, shares   3,819,485          
Proceeds received from private placement            
Currency translation gain\loss 15 15
Conversion of Series E preferred stock $ (1) $ 551 (550)  
Conversion of Series E preferred stock, shares (5,513) 5,511,543          
Common stock issued for acquisition of patents   $ 25 959,975 960,000
Common stock issued for acquisition of patents, shares   250,000          
Issue common stock for exercise of warrants   $ 2 55,789 55,791
Issue common stock for exercise of warrants, shares   17,731          
Break-up fee - issuance of shares to GBV   $ 300 2,849,700 2,850,000
Break-up fee - issuance of shares to GBV, shares   3,000,000          
Net Loss       (12,814,324) (12,814,324)
Ending balance at Dec. 31, 2018   $ 2,552 $ 105,459,482 $ (102,090,441) $ (450,719) $ 2,920,874
Ending balance, shares at Dec. 31, 2018   25,519,940